Keyphrases
Anticancer Immune Response
14%
Aryl
14%
Autoantigen
17%
B Cells
14%
Borrelia Burgdorferi
14%
Breast Cancer
14%
CD4+
16%
Disease Onset
17%
Effector T Cells
17%
Epstein-Barr Virus
14%
Glucocorticoid-induced
14%
Graft-versus-leukemia Effect
14%
Graves' Disease
35%
Hashimoto Disease
14%
HLA-DM
14%
Human Tissue
14%
Hydroxyl Group
14%
Hydroxymethyl
14%
Interleukin-13 (IL-13)
14%
Invariant Chain
14%
Invariant Natural Killer T Cells
18%
Invariant NKT Cells
22%
Leukemic Cells
14%
Lymphocytes
18%
Myeloid DC
14%
Neuroprotective Action
14%
NKT Cells
17%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
14%
Pancreas
19%
Pathway Alteration
14%
Phenylthio
14%
Phosphodiesterase Type 5 Inhibitors
14%
Phytoceramide
14%
Recent-onset
17%
Regulatory T (Treg) Cells
18%
Self-reactivity
14%
Spleen
14%
T Cell Lines
16%
T Cell Receptor
26%
T Cells
73%
T-cell Antigen
14%
T-cell Mediated
14%
TCR Bias
14%
Thyroid Follicular Cells
14%
Type 1 Diabetes Mellitus (T1DM)
34%
Type 1 Diabetic Patient
14%
Type I Diabetes
21%
Usage Profile
14%
Virus B
14%
Xenograft
14%
Immunology and Microbiology
Antigen Presentation
5%
Autoantigen
16%
Autoimmunity
13%
B Cell
14%
Borrelia burgdorferi
14%
CD1
14%
CD4
16%
CD8
13%
Cell Adhesion Proteins
14%
Cell Line
26%
Clone
9%
Cytokine
33%
Cytotoxic T Cell
14%
Epstein Barr Virus
14%
Glucocorticoid
14%
Graves' Disease
35%
Group 1 CD1
14%
Hashimoto's Thyroiditis
14%
HLA-DM
14%
Human Cell
14%
Human Tissue
14%
Immune Response
14%
Intercellular Adhesion Molecule 1
5%
Interleukin 13
14%
Interleukin 4
9%
Lymphocyte
22%
Myeloid
8%
Natural Killer T Cell
14%
Pancreas
20%
Peripheral Blood Lymphocyte
5%
Phytohaemagglutinin
14%
Regulatory T Cell
14%
Single Cell Analysis
14%
T Cell
100%
T Cell Receptor
41%
Thyroid
23%
Thyroid Follicular Cell
14%
TLR2
5%
Viral Disease
5%
Volume
7%
Xenograft
9%
